HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Packaging, amplification, and appraisal of the recombinant tumor-selective type I herpes simplex virus carrying GALV.fus gene.

Abstract
The aim of the study was to successfully construct three plasmids, which include the GALV.fus gene plasmid regulated by the herpes simplex virus type 1 (HSV-1) late expression gene-UL38 promoter and induced by HSV-1 (HSV-UL38P-GALV.fus), the cytomegalovirus promoter without tumor specificity (CMVP) GALV.fus plasmid (HSV-CMVP-GALV.fus), and the control plasmid in which the GALV.fus gene fragment was replaced by the enhanced green fluorescent protein (EGFP) gene fragment (HSV-CMVP-EGFP). The three constructed plasmids were all packaged and named as Synco-2, Synco-1, and Baco-1. The plasmids were amplified in coliform bacterium and transfected into Vero cells using lipofectamine. These recombinant HSV-1 were amplified in Vero cells and purified by conventional methods of cesium chloride, TCID50 method is used to measure virus titers. The total RNA was then extracted from the HepG2 cells transfected by Synco-1 and Synco-2, and the expression of GALV.fus mRNA was detected by RT-PCR. The three recombinant HSV-1 vectors were propagated in Vero cells and purified by cesium chloride density gradient centrifugation, titrated by TCID50 method, and packaged. The titers of Baco-1, Synco-1, and Synco-2 were 3 × 10(10), 1 × 10(11), and 4 × 10(10) pfu/ml. The GALV.fus gene was identified in the infected HepG2 cells by RT-PCR method.
AuthorsZhu Bing, Yang Jianru, Jiang Yuequan, Chen Shifeng, Fu Xinping
JournalCell biochemistry and biophysics (Cell Biochem Biophys) Vol. 70 Issue 1 Pg. 321-6 (Sep 2014) ISSN: 1559-0283 [Electronic] United States
PMID24687598 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Recombinant
  • RNA-Binding Protein FUS
  • RNA
Topics
  • Animals
  • Cercopithecus aethiops
  • DNA, Recombinant (genetics)
  • Genetic Engineering (methods)
  • Genetic Therapy
  • Hep G2 Cells
  • Herpesvirus 1, Human (genetics, physiology)
  • Humans
  • Leukemia Virus, Gibbon Ape (genetics)
  • Lung Neoplasms (genetics, therapy)
  • Nucleic Acid Amplification Techniques
  • Plasmids (genetics)
  • RNA (genetics, isolation & purification)
  • RNA-Binding Protein FUS (genetics)
  • Transfection
  • Vero Cells
  • Virus Assembly

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: